2012
DOI: 10.4244/eijv7i9a170
|View full text |Cite
|
Sign up to set email alerts
|

Stent implantation in aorto-ostial lesions: long-term follow-up and predictors of outcome

Abstract: AOL stenting can be performed with high success and low complication rates. At follow-up, no significant differences in event rates were found between DES and BMS; EuroSCORE>10% was the only predictor of MACCE.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
13
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(15 citation statements)
references
References 28 publications
2
13
0
Order By: Relevance
“…Iakovou et al reported angiographic res-tenosis rates of 51% in bare metal stents vs. 11% in sirolimus drug-eluting stents in the treatment of aortoostial lesions [27]. Recently, Luz et al published a TLR -rate of 13% with no significant difference between BMS vs. DES [28]. Other trials detected additional risk factors for restenosis, such as male gender [29].…”
Section: Follow-upmentioning
confidence: 97%
“…Iakovou et al reported angiographic res-tenosis rates of 51% in bare metal stents vs. 11% in sirolimus drug-eluting stents in the treatment of aortoostial lesions [27]. Recently, Luz et al published a TLR -rate of 13% with no significant difference between BMS vs. DES [28]. Other trials detected additional risk factors for restenosis, such as male gender [29].…”
Section: Follow-upmentioning
confidence: 97%
“…Right coronary aorto-ostial stenting can be performed with low in-hospital complication rates (7), but restenosis seems to be a problem at the long-term follow-up (8). In addition, percutaneous intervention on ostial RCA lesions has higher mortality and target lesion revascularization (TLR) rates during long-term follow-up compared to intervention on non-ostial RCA lesions (9).…”
Section: Introductionmentioning
confidence: 99%
“…Contemporary data showed that, compared to BMS the use of drug‐eluting stents (DES), has resulted in lower restenosis rates, target lesion revascularization and target vessel revascularization and fewer major adverse cardiac event rates . This data has been challenged more recently with studies showing that patients undergoing percutaneous coronary intervention (PCI) for aorto‐ostial disease, death and repeat revascularization did not differ between stent types . Aorto‐ostial lesions in the peripheral circulation (renal, subclavian, and mesenteric arteries) are reported to present similar challenges .…”
Section: Introductionmentioning
confidence: 99%